Kidney transplantation is the best treatment option for end stage renal disease and the impact of cancer affecting the transplanted graft is higher when compared to the general population. It significantly affects the patient quality of life, meaning return to dialysis, along with worse life expectancy. It is therefore envisaged to be able to discern between benign lesion treatable conservatively or with surveillance and those requiring graft nephrectomy. In particular, misdiagnosis of rare entities such as myelolipoma, could represent a challenge requiring dedicate expertise
Myelolipoma in the kidney transplant: a unique entity to be acknowledged / Bellini, M. I.; Magowan, H.; Houghton, O.; Reid, J.; Mcdaid, J.. - In: ULSTER MEDICAL JOURNAL. - ISSN 0041-6193. - 89:2(2020), pp. 128-129.
Myelolipoma in the kidney transplant: a unique entity to be acknowledged
Bellini M. I.
Primo
;
2020
Abstract
Kidney transplantation is the best treatment option for end stage renal disease and the impact of cancer affecting the transplanted graft is higher when compared to the general population. It significantly affects the patient quality of life, meaning return to dialysis, along with worse life expectancy. It is therefore envisaged to be able to discern between benign lesion treatable conservatively or with surveillance and those requiring graft nephrectomy. In particular, misdiagnosis of rare entities such as myelolipoma, could represent a challenge requiring dedicate expertise| File | Dimensione | Formato | |
|---|---|---|---|
|
Bellini_Myelolipoma-in-the-kidney-transplant_2020.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
673.33 kB
Formato
Adobe PDF
|
673.33 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
